Maximal chemiluminescent intensity in response to lipopolysaccharide assessed by endotoxin activity assay on admission day predicts mortality in patients with sepsis

Critical Care Medicine

Volumn 41, Issue 6, 2013, Pages 1443-1449

  Kiguchi, Takeyuki ^a   Nakamori, Yasushi ^a   Yamakawa, Kazuma ^b   Kitayama, Junichi ^a   Wada, Daiki ^a   Ogawa, Yoshihito ^b   Ogura, Hiroshi ^b   Kuwagata, Yasuyuki ^b   Shimazu, Takeshi ^b   Hamasaki, Toshimitsu ^b   Fujimi, Satoshi ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

chemiluminescent intensity; endotoxin activity assay; neutrophils; oxidative burst activity; prognostic value; sepsis

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE;

ADULT; AGED; APACHE; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;

AGED; APACHE; BIOLOGICAL MARKERS; HUMANS; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LIPOPOLYSACCHARIDES; LUMINESCENT MEASUREMENTS; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS;

EID: 84878526405     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31827ca960     Document Type: Article

References (35)

1. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis occurrence in acutely ill patients investigators: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34:344-353
2. Beale R, Reinhart K, Brunkhorst FM, et al: PROGRESS Advisory Board: Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an international sepsis registry. Infection 2009; 37:222-232
3. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic infammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273:117-123
4. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classifcation system. Crit Care Med 1985; 13:818-829
5. Jones AE, Trzeciak S, Kline JA: The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009; 37:1649-1654
6. Pettilä V, Hynninen M, Takkunen O, et al: Predictive value of procalci-tonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28:1220-1225
7. Harbarth S, Holeckova K, Froidevaux C, et al, Geneva Sepsis Network: Diagnostic value of procalcitonin, interleukin-6, and interleu-kin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164:396-402
8. Pierrakos C, Vincent JL: Sepsis biomarkers: A review. Crit Care 2010; 14:R15
9. Kofoed K, Andersen O, Kronborg G, et al: Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: A prospective study. Crit Care 2007; 11:R38
10. Romaschin AD, Harris DM, Ribeiro MB, et al: A rapid assay of endo-toxin in whole blood using autologous neutrophil dependent chemilu-minescence. J Immunol Methods 1998; 212:169-185
11. Marshall JC, Foster D, Vincent JL, et al; MEDIC study: Diagnostic and prognostic implications of endotoxemia in critical illness: Results of the MEDIC study. J Infect Dis 2004; 190:527-534
12. Bone RC, Balk RA, Cerra FB, et al: Defnitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
13. Dellinger R P, Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
14. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44:837-845
15. Akaike H: A new look at statistical model identifcation. IEEE Trans Autom Control 1974; 19:716-723
16. Lundberg JS, Perl TM, Wiblin T, et al: Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 1998; 26:1020-1024
17. Ferreira FL, Bota DP, Bross A, et al: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754-1758
18. Vincent JL, de Mendonça A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26:1793-1800
19. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103:565-575
20. Panacek EA, Marshall JC, Albertson TE, et al; Monoclonal Anti-TNF: A Randomized Controlled Sepsis Study Investigators: Effcacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004; 32:2173-2182
21. Patel RT, Deen KI, Youngs D, et al: Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994; 81:1306-1308
22. Fujishima S, Sasaki J, Shinozawa Y, et al: Serum MIP-1 alpha and IL-8 in septic patients. Intensive Care Med 1996; 22:1169-1175
23. Heper Y, Akalin EH, Mistik R, et al: Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 2006; 25:481-491
24. Wang CH, Gee MJ, Yang C, et al: A new model for outcome prediction in intra-abdominal sepsis by the linear discriminant function analysis of IL-6 and IL-10 at different heart rates. J Surg Res 2006; 132:46-51
25. Marchant A, Alegre ML, Hakim A, et al: Clinical and biological signif-cance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995; 15:266-273
26. Calandra T, Baumgartner JD, Grau GE, et al: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and inter-feron-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990; 161:982-987
27. Bozza FA, Salluh JI, Japiassu AM, et al: Cytokine profles as markers of disease severity in sepsis: A multiplex analysis. Crit Care 2007; 11:R49
28. Carrol ED, Thomson AP, Hart CA: Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002; 20:1-9
29. Clec'h C, Ferriere F, Karoubi P, et al: Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32: 1166-1169
30. Ruiz-Alvarez MJ, García-Valdecasas S, De Pablo R, et al: Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009; 24:63-71
31. Monti G, Bottiroli M, Pizzilli G, et al: Endotoxin activity level and septic shock: A possible role for specifc anti-endotoxin therapy? Contrib Nephrol 2010; 167:102-110
32. Martins PS, Kallas EG, Neto MC, et al: Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock 2003; 20:208-212
33. Hsu HY, Wen MH: Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 2002; 277:22131-22139
34. Stevens P, Winston DJ, Van Dyke K: In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemilumines-cence: Utility in patients with severe neutropenia and cellular def-ciency states. Infect Immun 1978; 22:41-51
35. Taneja R, Sharma AP, Hallett MB, et al: Immature circulating neutro-phils in sepsis have impaired phagocytosis and calcium signaling. Shock 2008; 30:618-622